S

Sahlgrenska University Hospital | Gothia Forum - Clinical Trial Center

Research site
(Unclaimed)
Location
Grona straket 12, Gothenburg, Västra Götalands län, Sweden

Site insights

Top conditions

Top treatments

Vincristine
Cyclophosphamide
ATB200
Doxorubicin Hydrochloride
Hydrocortisone
Doxorubicin
Dacarbazine
AT2221
Ruxolitinib
Atezolizumab

Parent organization

This site is a part of Sahlgrenska University Hospital

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 44 total trials

A 3-Arm Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty

The study is designed to compare three articulation options in terms of osteolysis, patient satisfaction, clinical and radiographic outcomes (Oxford...

Active, not recruiting
Arthritis
Pain
Procedure: Hip Arthroplasty

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor,...

Enrolling
Non Small Cell Lung Cancer
Drug: Docetaxel
Biological: Telisotuzumab Vedotin

This is a multicenter, international open-label extension study of ATB200/AT2221 in adult subjects with late-onset Pompe disease (LOPD) who completed...

Active, not recruiting
Pompe Disease (Late-onset)
Drug: AT2221
Biological: ATB200

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The purpose of t...

Enrolling
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Rituximab

The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...

Invitation-only
Atopic Dermatitis
Drug: Placebo
Drug: Upadacitinib

The specific study aim is to determine whether a 12-week digitally delivered behavior change intervention for patients with peripheral artery disease...

Active, not recruiting
Intermittent Claudication
Device: A PAD-specific smartphone application (e-intervention) developed for patients with Peripheral Artery Disease

This program initially aims to recruit 1300 breast cancer patients from a large number of hospitals across Europe. Eligible patients are those who ar...

Enrolling
Metastatic Breast Cancer
Procedure: metastatic lesion biopsy

This is a randomized, double-blind, placebo-controlled two-part study with a multiple escalating dose phase followed by a cohort expansion phase to a...

Enrolling
Heart Failure With Reduced Ejection Fraction
Drug: AC01

This a Phase 3, prospective, open-label, multicenter study of \[15-O\]-H2O injection for PET imaging of subjects with suspected CAD. Approximately 18...

Enrolling
Coronary Artery Disease
Drug: [O-15]-Water PET Myocardial Perfusion Imaging (MPI)

The purpose of this study is to evaluate the efficacy and safety of \[Lu-177\]-PNT2002 in patients with metastatic castration-resistant prostate canc...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Drug: Enzalutamide
Drug: Abiraterone

Myelofibrosis is a type of bone marrow cancer that usually develops slowly and disrupts body's normal production of blood cells. It causes bone marro...

Active, not recruiting
Myelofibrosis (MF)
Drug: Ruxolitinib
Drug: Navitoclax

The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin \& hydrocortisone (patients with con...

Begins enrollment in 2 months
Adrenal Insufficiency
Diabetes Mellitus
Drug: TID Hydrocortisone
Drug: OD dual-release Hydrocortisone

Trial sponsors

V
S
R
AbbVie logo
A
Amicus Therapeutics logo
A
Baxalta logo
B
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems